Fraud & Abuse

By John Barry
In Compliance
Apr 25th, 2012
0 Comments
In an attempt to stem health care fraud, the government’s use of Corporate Integrity Agreements (CIAs) is growing. In Professor Zack Buck’s Health Care Fraud and Abuse class here at Seton Hall Law, students were given the benefit of  a discussion on the topic by two industry veterans, Tim Grimes and Brett Bissey.  Grimes is […]...
By Zack Buck
In Fraud & Abuse
Apr 15th, 2012
2 Comments
News of the $1.2 billion verdict against Johnson & Johnson and its subsidiary Janssen Pharmaceuticals Inc. for their roles in marketing Risperdal during the middle of last decade sent reverberations through the industry earlier this week.  The award resolved Arkansas’ claims that the companies fraudulently marketed the “second generation” antipsychotic, misleading ...
By Guest Blogger
In Fraud & Abuse
Mar 15th, 2012
0 Comments
[Ed note: This article was authored by John Barry ’13, a second year law student pursuing a Health Care Concentration at Seton Hall Law.  A native of New York, he graduated in 2005 from the University of Pennsylvania with a degree is psychology.] Recently, Professor Zack Buck’s Health Care Fraud and Abuse class was treated […]...
By Katherine Matos
In Compliance
Oct 18th, 2010
0 Comments
On October 1, the Office of the Inspector General (“OIG”) of the U.S. Dept. of Health & Human Services (“HHS”) released its Work Plan for Fiscal Year 2011 (“Work Plan”).  Each year, the OIG briefly outlines activities that OIG “plans to initiate or continue with respect to the programs and operations” of HHS.  Various...
By Jordan T. Cohen
In Fraud & Abuse
Sep 29th, 2010
0 Comments
On September 23rd, 2010, Paul J. Fishman, United States Attorney for the District of New Jersey, provided insight into his state’s approach to prosecuting health care fraud. He spoke here at Seton Hall Law School, presented by our Center for Health & Pharmaceutical Law & Policy. First, some background on the U.S. Attorney. Mr. Fishman […]...